|
|
| Zydus Lifesciences Limited |
|
Financials-Zydus Lifesciences Limited| Sector: Formulations | | BSE:532321 | NSE:ZYDUSLIFE | Bloomberg:CDH@IN | Reuters:CADI.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE010B01027 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
19188.00 |
18486.00 |
3.80 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
250.00 |
388.00 |
-35.57 |
| Total Income |
19438.00 |
18874.00 |
2.99 |
| Total Expenses |
-15494.00 |
-15656.00 |
-1.03 |
| OPBDIT |
34932.00 |
34530.00 |
1.16 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-1131.00 |
-15656.00 |
-92.78 |
| Exceptional & Extraordinary Items |
-1875.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-666.00 |
-402.00 |
65.67 |
| After Tax Profit |
1403.00 |
2816.00 |
-50.18 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-08(12) |
|
31-Mar-07(12) |
|
31-Mar-06(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
16427.00 |
94.35 |
14402.00 |
98.53 |
12460.00 |
97.26 |
| Operating Income (OI) |
17411.00 |
100.00 |
14617.00 |
100.00 |
12811.00 |
100.00 |
| OPBDIT |
3314.00 |
19.03 |
2712.00 |
18.55 |
2422.00 |
18.91 |
| OPBDT |
2991.00 |
17.18 |
2379.00 |
16.28 |
2176.00 |
16.99 |
| OPBT |
2257.00 |
12.96 |
1712.00 |
11.71 |
1560.00 |
12.18 |
| Non-Operating Income |
528.00 |
3.03 |
607.00 |
4.15 |
439.00 |
3.43 |
| Extraordinary/Prior Period |
-145.00 |
-0.83 |
-30.00 |
-0.21 |
-196.00 |
-1.53 |
| Tax |
278.00 |
1.60 |
242.00 |
1.66 |
154.00 |
1.20 |
| Profit after tax(PAT) |
2362.00 |
13.57 |
2047.00 |
14.00 |
1649.00 |
12.87 |
| Cash Profit |
3096.00 |
17.78 |
2714.00 |
18.57 |
2265.00 |
17.68 |
| Dividend-Equity |
565.00 |
3.25 |
502.00 |
3.43 |
377.00 |
2.94 |
|
| As on |
31-Mar-08 |
|
31-Mar-07 |
|
31-Mar-06 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
9713.00 |
43.90 |
8595.00 |
48.00 |
7534.00 |
53.20 |
| Net Block |
6840.00 |
30.91 |
6163.00 |
34.42 |
5438.00 |
38.40 |
| Capital WIP |
964.00 |
4.36 |
521.00 |
2.91 |
589.00 |
4.16 |
| Investments |
4384.00 |
19.81 |
2885.00 |
16.11 |
1592.00 |
11.24 |
| Inventory |
3310.00 |
14.96 |
3287.00 |
18.36 |
2128.00 |
15.03 |
| Receivables |
2825.00 |
12.77 |
2386.00 |
13.33 |
1851.00 |
13.07 |
| Other Current Assets |
3803.00 |
17.19 |
2664.00 |
14.88 |
2564.00 |
18.10 |
| Balance Sheet Total(BT) |
22126.00 |
100.00 |
17906.00 |
100.00 |
14162.00 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
628.00 |
2.84 |
628.00 |
3.51 |
314.00 |
2.22 |
| Reserves |
8911.00 |
40.27 |
6943.00 |
38.77 |
5627.00 |
39.73 |
| Total Debt |
7389.00 |
33.40 |
4477.00 |
25.00 |
4332.00 |
30.59 |
| Creditors and Acceptances |
2582.00 |
11.67 |
3590.00 |
20.05 |
1822.00 |
12.87 |
| Other current liab/prov. |
2616.00 |
11.82 |
2268.00 |
12.67 |
2067.00 |
14.60 |
| Balance Sheet Total(BT) |
22126.00 |
100.00 |
17906.00 |
100.00 |
14162.00 |
100.00 |
|
| As on |
31-Mar-08 |
31-Mar-07 |
31-Mar-06 |
| OPBIT/Prod.cap.empl.(%) |
22.36 |
23.78 |
23.06 |
| PBIT/Cap. Employed (%) |
18.56 |
22.75 |
21.16 |
| PAT/Networth (%) |
24.76 |
27.04 |
27.76 |
| Tax/PBT (%) |
10.53 |
10.57 |
8.54 |
| Total Debt/Networth (x) |
0.77 |
0.59 |
0.73 |
| Long Term Debt/Networth (x) |
0.46 |
0.41 |
0.19 |
| PBDIT/Finance Charges (x) |
11.45 |
9.88 |
10.83 |
| Current Ratio (x) |
1.91 |
1.42 |
1.68 |
| RM Inventory (days consumption) |
140.00 |
157.90 |
128.49 |
| FG inventory (days cost of sales) |
35.45 |
39.37 |
35.27 |
| Receivables (days gross sales) |
59.98 |
56.99 |
51.64 |
| Creditors (days cost of sales) |
66.85 |
110.07 |
64.01 |
| Op. curr. assets (days OI) |
165.00 |
185.00 |
145.00 |
|
|
Financials